A Dose-Optimization Study of the Efficacy, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years with Attention-Deficit/Hyperactivity Disorder | Zendy

AI Assistant Blog Pricing

A Dose-Optimization Study of the Efficacy, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years with Attention-Deficit/Hyperactivity Disorder

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.